Discontinued — last reported Q3 '25

Equity

Redeemable NCI

Markel Redeemable NCI increased by 2.7% to $519.75M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.3%, from $579.74M to $519.75M. Over 5 years (FY 2020 to FY 2025), Redeemable NCI shows an upward trend with a 15.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ3 2025

How to read this metric

An increase indicates higher potential future cash obligations to minority partners, which may impact liquidity and capital allocation flexibility.

Detailed definition

This represents equity interests in subsidiaries held by third parties that include redemption features, such as a manda...

Peer comparison

Often found in companies with complex joint venture structures or partially owned infrastructure projects; peers report this outside of permanent equity.

Metric ID: redeemable_noncontrolling_interests

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$228.40M$231.91M$461.38M$480.35M$495.38M$513.04M$523.15M$491.88M$464.44M$467.39M$469.69M$499.99M$476.52M$515.49M$540.03M$579.74M$531.34M$536.05M$506.06M$519.75M
QoQ Change+1.5%+98.9%+4.1%+3.1%+3.6%+2.0%-6.0%-5.6%+0.6%+0.5%+6.5%-4.7%+8.2%+4.8%+7.4%-8.3%+0.9%-5.6%+2.7%
YoY Change+116.9%+121.2%+13.4%+2.4%-6.2%-8.9%-10.2%+1.6%+2.6%+10.3%+15.0%+15.9%+11.5%+4.0%-6.3%-10.3%
Range$228.40M$579.74M
CAGR+18.9%
Avg YoY Growth+17.1%
Median YoY Growth+3.3%

Frequently Asked Questions

What is Markel's redeemable nci?
Markel (MKL) reported redeemable nci of $519.75M in Q1 2026.
How has Markel's redeemable nci changed year-over-year?
Markel's redeemable nci decreased by 10.3% year-over-year, from $579.74M to $519.75M.
What is the long-term trend for Markel's redeemable nci?
Over 5 years (2020 to 2025), Markel's redeemable nci has grown at a 15.6% compound annual growth rate (CAGR), from $245.64M to $506.06M.
What does redeemable nci mean?
Ownership stakes held by others in a subsidiary that the company may be required to buy back in the future.